Literature DB >> 15940377

Racial differences in rate of decline in bone mass in older men: the Baltimore men's osteoporosis study.

J Kathleen Tracy1, Walter A Meyer, Raymond H Flores, P David Wilson, Marc C Hochberg.   

Abstract

UNLABELLED: Older black men have higher adjusted BMD than older white men. Using data from a longitudinal cohort study of older men followed for a mean of 18.8 +/- 6.5 (SD) months, we found that older black men have a higher rate of decline in femoral neck and total hip BMD and femoral neck BMAD than older white men.
INTRODUCTION: Older black men have higher adjusted BMD compared with older white men. The difference in BMD may be caused by having attained higher peak bone mass as young adults and/or having a slower rate of decline in bone mass as adults. There are few published longitudinal data on change in bone mass in older white men and no published data for older black men.
MATERIALS AND METHODS: Three hundred forty-nine white men and 119 black men 65 of age (mean age, 75 +/- 5.7 and 72 +/- 5.6 years, respectively) who participated in the longitudinal component of the Baltimore Men's Osteoporosis Study returned for a second visit after a mean of 18.8 +/- 6.5 (SD) months and were not taking medications used to treat low bone mass at either visit. BMD was measured at the femoral neck and total hip by Hologic-certified technicians using a QDR 2000 at the baseline visit (V1) and QDR 4500 at the first follow-up visit (V2). Participants also completed self-administered and interviewer-administered questionnaires and underwent standardized clinic examinations. Bone mineral apparent density (BMAD) at the femoral neck was calculated as an estimate of volumetric BMD. Annual crude and multiple variable adjusted percent changes in BMD and BMAD were calculated.
RESULTS: In univariate analyses, black men had lower percent decline in femoral neck and total hip BMD and femoral neck BMAD than white men. In addition, older age at baseline, lower baseline weight, current smoking, and lower baseline BMD were associated with greater percent decline per year in femoral neck BMD; older age at baseline, current smoking, and lower baseline BMD were associated with greater percent decline per year in total hip BMD; and older age at baseline and lower baseline femoral neck BMAD were associated with greater percent decline per year in femoral neck BMAD. Racial differences in bone loss persisted in multiple variable models that controlled for other factors associated with change in BMD and BMAD.
CONCLUSIONS: Older black men seem to lose bone mass at a slower rate than older white men. These differences in the rate of bone loss may account, in part, for the racial disparities in BMD and BMAD and risk of osteoporotic fractures among older men.

Entities:  

Mesh:

Year:  2005        PMID: 15940377     DOI: 10.1359/JBMR.050310

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  37 in total

1.  Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.

Authors:  Jie Zhang; David T Redden; Gerald McGwin; Leigh F Callahan; Edwin A Smith; Graciela S Alarcón; Larry W Moreland; Désirée M van der Heijde; Elizabeth E Brown; Donna K Arnett; Ted R Mikuls; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2010-08

2.  Change in hip bone mineral density and risk of subsequent fractures in older men.

Authors:  Peggy M Cawthon; Susan K Ewing; Dawn C Mackey; Howard A Fink; Steven R Cummings; Kristine E Ensrud; Marcia L Stefanick; Doug C Bauer; Jane A Cauley; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

3.  Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation clinic.

Authors:  M Reuss-Borst; U Hartmann; C Scheede; J Weiß
Journal:  Osteoporos Int       Date:  2011-07-14       Impact factor: 4.507

4.  The relationship between body composition and bone mineral content: threshold effects in a racially and ethnically diverse group of men.

Authors:  T G Travison; A B Araujo; G R Esche; J B McKinlay
Journal:  Osteoporos Int       Date:  2007-07-28       Impact factor: 4.507

Review 5.  The uncertain significance of low vitamin D levels in African descent populations: a review of the bone and cardiometabolic literature.

Authors:  Michelle Y O'Connor; Caroline K Thoreson; Natalie L M Ramsey; Madia Ricks; Anne E Sumner
Journal:  Prog Cardiovasc Dis       Date:  2013 Nov-Dec       Impact factor: 8.194

6.  IMPACT OF WEIGHT LOSS AND AEROBIC EXERCISE ON NUTRITION AND BONE MINERAL DENSITY IN AFRICAN AMERICAN AND CAUCASIAN POSTMENOPAUSAL WOMEN.

Authors:  M C Serra; J B Blumenthal; A S Ryan
Journal:  J Aging Res Clin Pract       Date:  2013-03

7.  Racial differences in cortical bone and their relationship to biochemical variables in Black and White children in the early stages of puberty.

Authors:  S J Warden; K M Hill; A J Ferira; E M Laing; B R Martin; D B Hausman; C M Weaver; M Peacock; R D Lewis
Journal:  Osteoporos Int       Date:  2012-10-24       Impact factor: 4.507

8.  Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox.

Authors:  Marcella D Walker; Donald J McMahon; Julia Udesky; George Liu; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

9.  Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men.

Authors:  Marian T Hannan; Heather J Litman; Andre B Araujo; Christine E McLennan; Robert R McLean; John B McKinlay; Tai C Chen; Michael F Holick
Journal:  J Clin Endocrinol Metab       Date:  2007-11-06       Impact factor: 5.958

10.  Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.

Authors:  Alicia K Morgans; Matthew R Smith; A James O'Malley; Nancy L Keating
Journal:  Cancer       Date:  2012-10-12       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.